Program
Introduction
  • Johan Aune, Takeda
  • Experiences with the use of EHL in the treatment of Hem A
  • Professor Pål André Holme, Rikshospitalet
  • Q&A

    Pål André Holme

    Professor of Hematology, MD, PhD at Oslo University Hospital, Rikshospitalet

    Pål André Holme is chief medical officer at the Department of blood diseases, Oslo University Hospital, where he is responsible for bleeding disorders. He’s a professor at the Institute of Clinical Medicine, University of Oslo.

    Best regards,

    Johan Aune

    Brand and Customer Manager RMD and Hemophilia

    E-mail: johan.aune@takeda.com

    Mobil +4790872306

    C-APROM/NO/ADYN/0015

    (Denne annonsen er kun ment for helsepersonell)
    (Denne annonsen er kun ment for helsepersonell)